Stryker is preparing to undergo a major transformation by selling its spinal implant business to the family investment firm Viscogliosi Brothers. This decision marks a strategic turning point for the company, seeking to refocus on its priorities while providing this new entity, called VB Spine, the opportunity to specialize in neuro-musculoskeletal products. At the heart of this transition, Stryker also aims to strengthen its position in the innovative medical device market. The sale will include a binding offer to acquire the products from the implant range in France, thus raising significant issues for the future of the sector.
Stryker, one of the major players in the medical sector, recently announced its decision to divest its spinal implant business. This initiative is part of a broader strategy aimed at refocusing the company’s efforts on innovative products and optimizing its resources. The decision to sell this division is even more significant given the growing demand for advanced technological solutions in healthcare.
The agreement with Viscogliosi Brothers
As part of this transaction, Stryker has entered into an agreement with the family investment firm Viscogliosi Brothers. This company, specialized in products related to the neuromuscular system, aims to strengthen its portfolio. The agreement also includes an offer